Grifols launches next-gen immunohematology sample processing system

July 2026—Grifols launched at the International Society of Blood Transfusion Congress (Kuala Lumpur, Malaysia, June 20–24) the Evanzys IH, a modular, fully automated, track-enabled system designed to streamline operations and reduce manual intervention in immunohematology sample processing.

“Evanzys IH represents a major milestone in our commitment to advancing innovation in transfusion medicine. With this new modular, track-enabled solution—the most innovative platform in the field—we are empowering laboratories to meet increasing automation demands while upholding the highest standards of quality, safety, and efficiency,” Antonio Martínez, president of Grifols Diagnostic, said in a press release.

The launch expands the company’s portfolio of scalable blood typing solutions, with the aim of helping health care professionals deliver safer and faster transfusion results while addressing the evolving needs of laboratories.

Grifols, 888-474-3657